GotoPER - Physicians' Education Resource
Back to Home|Learning Hub

10th Annual Live Medical Crossfire®:
Hematologic Malignancies - Learning Hub

Stay up to date with advances in diagnosis and management of hematologic malignancies through the 10th Annual Live Medical Crossfire®: Hematologic Malignancies Learning Hub.

Designed for easy, on-demand online access, the Learning Hub features state of the art lectures in the diagnosis and management of hematologic malignancies, a keynote address on the emerging role of monitoring minimal residual disease results, and workshops on new findings regarding CAR T-cell therapy and bispecifics in the management of hematologic malignancies. The Learning Hub includes slides and CME evaluation questions. If you attended the meeting, it offers another opportunity to learn from world-renowned experts. If you were not available to attend, it offers the experience of learning from expert presentations and discussions on new and emerging data in the management of leukemia, lymphoma, and multiple myeloma. The goal of the meeting is always to provide the latest clinical information in a way that allows rapid application to patients seen in daily practice.

This activity is supported by educational grants from AstraZeneca Pharmaceuticals; Janssen Scientific Affairs, LLC; and Lilly.

9 Modules
Aug 17, 2026 – Aug 18, 2027

Browse and take individual modules below, or enroll in the full path to track your overall progress.

Register to Track ProgressLogin

Main Conference

Module 1: Medical Crossfire in Leukemia
Module 1

Module 1: Medical Crossfire in Leukemia

Barbara Pro, MD; Amer Zeidan, MD, MBBS; Brandon DaSilva, MD; Alessandra Ferrajoli, MD; Nicole Lamanna, MD; Marlise Luskin, MD, MSCE; Razan Mansour, MD; Lourdes Mendez, MD, PhD; Alice Mims, MD; Maximilian Stahl, MD; Cristian Taborda, MD

View Module

Slide Downloads

      Module 2: Keynote: Evidence for MRD as a Biomarker Across Hematologic Malignancies
      Module 2

      Module 2: Keynote: Evidence for MRD as a Biomarker Across Hematologic Malignancies

      Saad Z. Usmani, MD, MBA, FACP, FASCO; Mikhail Roshal, MD, PhD

      View Module

      Slide Downloads

          Module 3: Current Challenges in the Management of Follicular Lymphoma
          Module 3

          Module 3: Current Challenges in the Management of Follicular Lymphoma

          Barbara Pro, MD; Joshua Brody, MD; Hua-Jay “Jeff” Cherng, MD; Brandon DaSilva, MD; Patrick Gould, MD; Prashant Kapoor, MD, FACP

          View Module

          Slide Downloads

            Module 4: Medical Crossfire in Smoldering Multiple Myeloma
            Module 4

            Module 4: Medical Crossfire in Smoldering Multiple Myeloma

            Saad Z. Usmani, MD, MBA, FACP, FASCO; Patrick Gould, MD; Prashant Kapoor, MD, FACP; Mansi R. Shah, MD

            View Module

            Slide Downloads

                Module 5: Medical Crossfire in Newly Diagnosed and Relapsed Refractory Multiple Myeloma
                Module 5

                Module 5: Medical Crossfire in Newly Diagnosed and Relapsed Refractory Multiple Myeloma

                Saad Z. Usmani, MD, MBA, FACP, FASCO; Noffar Bar, MD; Charalampos Charalampous, MD; Patrick Gould, MD; Thomas Martin, MD; Andrew Yee, MD

                View Module

                Slide Downloads

                  Module 6: Workshop 2: Update in MPN
                  Module 6

                  Module 6: Workshop 2: Update in MPN

                  Amer Zeidan, MD, MBBS; Prithviraj Bose, MD; Fadi Haddad, MD; Cristian Taborda, MD

                  View Module

                  Slide Downloads

                      Module 7: Workshop 2: Update in MDS and CML
                      Module 7

                      Module 7: Workshop 2: Update in MDS and CML

                      Saad Z. Usmani, MD, MBA, FACP, FASCO; Charalampos Charalampous, MD; Jae H. Park, MD; Ran Reshef, MD, MSc; Shambavi Richard, MD

                      View Module

                      Slide Downloads

                          Module 8: Workshop 3: Update in CAR T-cell Therapy in Hematologic Malignancies
                          Module 8

                          Module 8: Workshop 3: Update in CAR T-cell Therapy in Hematologic Malignancies

                          Saad Z. Usmani, MD, MBA, FACP, FASCO; Charalampos Charalampous, MD; Jae H. Park, MD; Ran Reshef, MD, MSc; Shambavi Richard, MD

                          View Module

                          Slide Downloads

                            Module 9: Workshop 4: Update in Bispecific Therapies for Hematologic Malignancies
                            Module 9

                            Module 9: Workshop 4: Update in Bispecific Therapies for Hematologic Malignancies

                            Barbara Pro, MD; Brandon DaSilva, MD; Lorenzo Falchi, MD; Thomas Martin, MD; Alain Mina, MD

                            View Module

                            Slide Downloads